| Crit. Rev. Oncol. Hematol.
| [0003]
|
| Proc. Natl. Acad. Sci. USA
| [0003]
|
| Eur. J. Surg. Oncol.
| [0003]
|
| J. Clin. Oncol.
| [0003]
|
| Cancer Sci.
| [0003]
|
| Lab. Invest.
| [0003]
|
| Br. J. Cancer
| [0003]
|
| Neoplasia
| [0003]
|
| Cancer Res.
| [0003]
|
| Clin. Cancer Res.
| [0003]
|
| Nature
| [0003]
|
| Int. J. Cancer
| [0003]
|
| Int. J. Mol. Med.
| [0003]
|
| Nat. Genetics
| [0004]
|
| Proc. Natl. Acad. Sci. USA
| [0004]
|
| FEBS Letters
| [0004]
|
| Handbook of Pharmaceutical Salts: Properties, Selection, and Use
| [0258]
|
| J Pharm Sci
| [0262]
|
| Pro-drugs as Novel Delivery Systems
| [0263]
|
| Bioreversible Carriers in Drug Design
| [0263]
|
| Design of Prodrugs
| [0264]
|
| Stereochemistry of Organic Compounds
| [0279]
|
| Remington's Pharmaceutical Sciences
| [0321]
|
| Expert Opinion in Therapeutic Patents
| [0325]
|
| Pharmaceutical Dosage Forms: Tablets
| [0333]
|
| Pharmaceutical Technology On-line
| [0335]
|
| J Pharm Sci
| [0341]
|
| CHEMICAL ABSTRACTS
| [0503]
|